content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0002032353</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001819790</issuerCik>
        <issuerName>Tarsus Pharmaceuticals, Inc.</issuerName>
        <secFileNumber>001-39614</secFileNumber>
        <issuerAddress>
          <com:street1>15440 LAGUNA CANYON ROAD</com:street1>
          <com:city>IRVINE</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92618</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>(949) 409-9820</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>FLYING L PARTNERS XI LLC</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Director</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Class A</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Merrill Lynch</name>
          <address>
            <com:street1>555 California Street</com:street1>
            <com:street2>18th Floor</com:street2>
            <com:city>San Francisco</com:city>
            <com:stateOrCountry>CA</com:stateOrCountry>
            <com:zipCode>94104</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>35000</noOfUnitsSold>
        <aggregateMarketValue>939750.00</aggregateMarketValue>
        <noOfUnitsOutstanding>37781693</noOfUnitsOutstanding>
        <approxSaleDate>08/12/2024</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Class A</securitiesClassTitle>
        <acquiredDate>12/13/2019</acquiredDate>
        <natureOfAcquisitionTransaction>Private Placement</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>35000</amountOfSecuritiesAcquired>
        <paymentDate>12/13/2019</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>08/12/2024</noticeDate>
        <signature>Jeevan Gore</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2765}]
text: 144
  0002032353
  XXXXXXXX
  LIVE
  0001819790
  Tarsus Pharmaceuticals, Inc.
  001-39614
  15440 LAGUNA CANYON ROAD
  IRVINE
  CA
  92618
  (949) 409-9820
  FLYING L PARTNERS XI LLC
  Director
  Class A
  Merrill Lynch
  555 California Street
  18th Floor
  San Francisco
  CA
  94104
  35000
  939750.00
  37781693
  08/12/2024
  NASDAQ
  Class A
  12/13/2019
  Private Placement
  Issuer
  N
  35000
  12/13/2019
  Cash
  Y
  08/12/2024
  Jeevan Gore